Table 5.
Association between CAT score, V/Q scintigraphy defects or HRCT findings with diffusion capacity (DLco %predicted) in patients 4 months after COVID-19 (n = 64) using univariate linear regression.
| B | 95% CI | p-Value | |
|---|---|---|---|
| Clinical findings | |||
| CAT score | −0.89 | −1.58;−0.19 | 0.013 |
| HRCT findings | |||
| GGO extent * | −1.64 | −2.19;−1.10 | <0.001 |
| PF extent * | −2.67 | −3.74;−1.60 | <0.001 |
| SPECT findings | |||
| Number of V/Q defects | −1.52 | −2.66;−0.39 | 0.009 |
| Number of mismatched Q defects | −2.09 | −5.22;1.03 | 0.186 |
| Number of matched V/Q defects | −3.69 | −7.03;−0.34 | 0.031 |
| Number of reversed V defects | −0.98 | −2.29;0.34 | 0.143 |
* Data missing from one patient (n = 63). CAT score: chronic obstructive pulmonary disease assessment test, GGO: ground-glass opacities, PF: pulmonary fibrosis.